Navigation Links
ClearTrial Unveils New Product Release at Partnerships in Clinical Trials Conference 2010
Date:4/12/2010

ClearTrial v3.2 Enables Organizations to Achieve Greater Control and Increased Accuracy When Managing Complex, Global Clinical Studies

Orlando, FL (PRWEB) April 12, 2010 -- ClearTrial (www.cleartrial.com), the leading provider of Clinical Trial Operations (CTO) software, today launched ClearTrial v3.2, a major upgrade to its award-winning ClearTrial PLAN, ClearTrial SOURCE, and ClearTrial TRACK products. ClearTrial v3.2 helps pharmaceutical, biotechnology and medical device companies meet the increasingly challenging demands of planning, sourcing, and tracking studies – challenges driven by a more complex and global clinical development environment.

"Our ongoing research indicates that clinical research protocols are being conducted in more global locations at the same time that they are increasingly more complex and demanding," said Kenneth Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development. "These factors present significant challenges to the industry as it strives to achieve higher levels of efficiency and productivity."

ClearTrial v3.2 is based on extensive industry research as well as comprehensive input from ClearTrial's global customer base, which ranges from the Top 20 sponsors to small biotech and medical device companies in the US, Europe, and Japan. The latest software release includes a number of new features and product enhancements that give trial sponsors more granular control over the clinical assumptions that drive study cost, resource demand, and timelines. These enhancements also provide for greater accuracy in forecasting – improving on the leading standard established by ClearTrial, which has been benchmarked to 1-5% accuracy when compared with actual study costs.

For global studies and for trial
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
2. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
3. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
4. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
5. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
6. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
7. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
8. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
9. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
10. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
11. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... -- Techne Corporation (NASDAQ: TECH ) (Techne) ... 100% ownership of Bionostics Holdings Limited and its ... global leader in the development, manufacture and distribution ... of in vitro diagnostic (IVD) devices ... and blood gas testing.  Biosnostics has strategic supply ...
(Date:6/18/2013)... Research and Markets ... of the "Injectable Drug Delivery Market ... [Disposables & Reusable, Fillable & Prefilled, Pen, ... [Diabetes & Oncology] - Global Forecasts to ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ...
(Date:6/18/2013)... 2013 Research ... announced the addition of the ... Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], ... (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - ... their offering.      (Logo: ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3
... Timely Hearing before a NASDAQ Listing ... Qualifications Panel -, ... VRMLD) (the "Company"), a molecular diagnostics company,announced today that on March ... that, as a result of the Company,s,common stock closing at $1.00 ...
... Corp. (Nasdaq: MEMY ) today reported that ... explanatory,paragraph in their opinion on the Company,s financial ... Form 10-K for the year ended,December 31, 2007, ... a going,concern. The Company discusses this matter, including ...
... Organization,s National Networking ... And Expo ... (DA4S) (http://www.diversityallianceforscience.com ) has announced,that Merck & Co., Inc. will ... scheduled for May 19-20 at the Westin,Governors in Morristown, N.J. The ...
Cached Biology Technology:Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 2Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 3Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 4Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification 2Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Science's Inaugural Conference 2
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... female sex workers in India reduce rates of syphilis, ... of Toronto study has found. , About ... the southern states of Andhra Pradesh, Karnataka, Maharashtra and ... from U of T,s Dalla Lana School of Public ... Research (CGHR), examined the impact of prevention among female ...
(Date:6/16/2013)... and move around the body called ,chase and run, ... at UCL. , Published in Nature Cell Biology ... when cancer cells interact with healthy cells in order to ... cells recruit healthy cells and use them to travel long ... could be controlled to design new therapies against cancer remains ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2'Chase and run' cell movement mechanism explains process of metastasis 2
... scientists to track the habitat preferences and movements of ... managers protect overfished species such as red snapper and ... current online edition of the peer-reviewed Bulletin of ... exactly what areas to protect," says Matt Kendall, principle ...
... Results of the first study evaluating the use of human ... crops has found that the combination can be substituted for ... introducing any risk of disease for consumers. The study appears ... and Food Chemistry , a bi-weekly publication. In ...
... regulate the energy consumption of cells have a different structure ... healthy people, according to a new study from the Swedish ... The researchers believe that these ,epigenetic mutations, might have a ... Type II diabetes is characterised by a lower ...
Cached Biology News:NOAA scientists map fish habitat and movements at Gray's Reef Marine Sanctuary 2
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: